Read the full guides
Bronchogen
Last reviewed: July 13, 2026 by The Peptide Catalog Team
A Khavinson bronchial tetrapeptide (Ala-Glu-Asp-Leu / AEDL) studied in rat lung models for respiratory-tissue repair; preclinical, no human data. Bronchogen is a bronchial peptide bioregulator studied for respiratory tissue support.
Overview
Core Benefits
Key AdvantagesThese are educational summaries of commonly discussed effects in wellness/regenerative contexts, not guarantees.
Bronchogen Results Timeline
ProgressionTimeline is illustrative and non-guaranteed. Outcomes vary and are commonly discussed alongside training, nutrition, sleep, and cycling practices.
How It WorksShort-Peptide Bioregulator — Bronchial / Respiratory (Preclinical Evidence Only)
Target → Signal → Effect → Outcomes
Bronchial Tissue / Gene Promoters (proposed)
Bronchogen is the tetrapeptide Ala-Glu-Asp-Leu (AEDL) from the Khavinson program. The hypothesis is tissue-specific regulation of bronchial-cell gene expression — modeled in-vitro, not confirmed in humans.
Bronchial Repair & Differentiation (animal/in-vitro)
In rat obstructive-lung models and cell culture, the group reported reduced airway remodeling and induction of bronchial-differentiation markers. These are preclinical findings framed as a proposed tissue-specific signal.
Respiratory-Tissue Repair (Animal Models)
The organism-level data is rat lung pathology models only. There is no human data of any kind for Bronchogen.
Unknown in Humans
No human evidence exists to predict a felt effect. Reported effects were in rat tissue and cell culture, not human experience.
What Makes This Peptide Different
Bronchogen is a research tetrapeptide (AEDL) — a tissue-specific bronchial bioregulator in the Khavinson framework. Its evidence is entirely rat lung models and in-vitro differentiation from one research lineage; no human data, no approval, no established dose.
Bronchogen Vendors
EZ Peptides
Dosing ProtocolRespiratory-Tissue Support (Research / No Human Data)
Educational reference only. Individual responses vary. Consult healthcare provider before use.
Why This Dosing Protocol
Why short courses? Convention by analogy to Khavinson-program pulse dosing, not a tested Bronchogen protocol.
Reconstitution Calculator
Dilution math and unit conversions. Prefilled using a common vial size for this peptide.
Open calculatorStorage & Handling
Storage at a glance
Proper storage temperatures, shelf life, reconstitution best practices, and travel tips for lyophilized and reconstituted peptides.
Handling specifics
Educational overview on storage, labeling, and traceability considerations for lab environments. Consult primary literature and vendor documentation for specifics.
- Freezer (-20°C): 1+ year
- Refrigerator (2-8°C): 1-3 months
- Room temperature: 2-3 weeks (emergency only)
- MUST refrigerate at 2-8°C
- 4-week maximum shelf life
- NEVER freeze after reconstitution
- Use bacteriostatic water for multi-dose
FAQ
What is Bronchogen?
Bronchogen is a synthetic bronchial tetrapeptide — Ala-Glu-Asp-Leu, or AEDL — from the Russian Khavinson bioregulator program. It is marketed for respiratory-tissue support. In rat models of obstructive lung disease and in cell culture, the Khavinson group reported effects on bronchial-epithelium repair and differentiation. There are no human trials.
How strong is the evidence behind Bronchogen?
Weak and preclinical only. The data is rat lung models and in-vitro differentiation studies from a single research lineage, with no human data and no independent replication. It is sold as a research chemical.
Is Bronchogen a treatment for lung conditions?
No. There is no clinical evidence that Bronchogen treats any respiratory condition in humans. Reported effects come from animal and cell studies only, and it is not approved for any use.
How long does reconstituted peptide last?
Once mixed with bacteriostatic water, peptides remain stable for up to 4 weeks when refrigerated at 2-8°C (36-46°F). Unopened powder can last 1+ year in the freezer. Get our complete Storage & Travel Guide.
Is this peptide legal to purchase?
Peptides sold "for research purposes only" are legal to purchase in the US, but are not FDA-approved for human use outside of specific medical applications. Always consult a healthcare provider before use.
New to peptides?
Take our Peptide Match tool to find the best peptide for your goals. You can also read our Complete Guide to Peptides to learn the basics.
Bronchogen Research Articles
Bronchogen Dosage Chart: 10-20 Day Course Protocol
A synthetic bronchial tetrapeptide with no validated dose. What research-chem sources report for short courses, plus the extract-vs-synthetic caveat.
side-effectsBronchogen Side Effects: What the Evidence Shows
Its makers claim near-zero side effects, but independent respiratory safety data barely exists. What the rat studies show — and the risks left out.
resultsBronchogen Results: Week-by-Week Timeline
Bronchogen has no human efficacy trials — so what drives the reported timelines? Rat COPD-model data and labeled community reports, week by week.
reconstitutionBronchogen Reconstitution: 20mg Vial Mixing Chart
Bronchogen has no validated human concentration. See how community resources describe mixing the 20mg vial, plus syringe-unit math and storage rules.
Disclosure: we may earn affiliate commission from qualifying purchases. Educational information only — not medical advice.